[1]王隽书 杨光燃.亚临床甲状腺功能减退症动物模型的研究进展[J].国际内分泌代谢杂志,2018,38(04):247-250.[doi:10.3760/cma.j.issn.1673-4157.2018.04.007]
 Wang Junshu,Yang Guangran..Recent progress of subclinical hypothyroidism animal models[J].International Journal of Endocrinology and Metabolism,2018,38(04):247-250.[doi:10.3760/cma.j.issn.1673-4157.2018.04.007]
点击复制

亚临床甲状腺功能减退症动物模型的研究进展()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年04期
页码:
247-250
栏目:
综述
出版日期:
2018-07-20

文章信息/Info

Title:
Recent progress of subclinical hypothyroidism animal models
作者:
王隽书 杨光燃
100730 北京,首都医科大学附属同仁医院内分泌科
Author(s):
Wang Junshu Yang Guangran.
Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
关键词:
亚临床甲状腺功能减退症 促甲状腺激素 动物模型
Keywords:
Subclinical hypothyroidism Thyrotrophin Animal models
DOI:
10.3760/cma.j.issn.1673-4157.2018.04.007
摘要:
近年来,为了更好的研究亚临床甲状腺功能减退症的发病机制,国内外学者纷纷尝试建立各种亚临床甲状腺功能减退症动物模型。查阅既往文献,亚临床甲状腺功能减退症动物造模方法有以下4种:应用抗甲状腺药物造模,手术切除甲状腺后再补充左甲状腺素造模,单侧甲状腺电凝毁损法造模,基因敲除的方法造模。各种造模方法各有其优势和弊端。成功建立亚临床甲状腺功能减退症动物模型,对其发病机制的进一步研究及其指导临床治疗具有重要意义。
Abstract:
In recent years, scholars domestically and abroad have tried to establish all kinds of subclinical hypothyroidism animal models in order to study its pathogenesis. According to previous literature review, four kinds of methods about inducing subclinical hypothyroidism animal models are introduced: administration of anti-thyroid drug, supplementation with levothyroxine after surgical removal of thyroid gland, hemi-thyroid electrocauterization, the method of gene knockout. Each method possesses its own advantages and disadvantages. Successful establishment of subclinical hypothyroidism animal models is very important for the studies of the pathogenesis and clinical treatment.

参考文献/References:


[1] Akter N,Qureshi NK, Ferdous HS. Subclinical hypothyroidism: a review on clinical consequences and management strategies [J]. J Med, 2017, 18(1): 30-36.DOI:10.3329/jom.v18i1.31174.
[2] 王秋虹,魏军平.亚临床甲状腺功能减退症实验研究进展[J].福建中医药,2012,43(4): 63-64.DOI:10.13260/j.cnki.jfjtcm.010409.
[3] Shan Z,Chen L,Lian X,et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities[J].Thyroid,2016,26(8):1125-1130.DOI:10.1089/thy.2015.0613.
[4] 赵静,苟云久.甲状腺功能低下动物模型研究进展[J].中兽医医药杂志,2015,3: 75-78.DOI:10.13823/j.cnki.jtcvm.2015.03.029.
[5] Song Y,Zhang X,Chen W,et al.Cholesterol synthesis increased in the MMI-induced subclinical hypothyroidism mice model[J].Int J Endocrinol,2017,2017:7921071. DOI:10.1155/2017/7921071.
[6] Wu K,Zhao M,Ma C,et al.Thyrotropin alters T cell development in the thymus in subclinical hypothyroidism mouse model[J].Scand J Immunol,2017,85(1):35-42.DOI:10.1111/sji.12507.
[7] Issa NM, El-Sherif NM. Effect of ginseng on the testis of subclinical hypothyroidism model in adult male albino rat [J]. Austin J Anat, 2017,4(2): 1065.
[8] 梁少珍,吴丽彩,黄翠莹.观察不同剂量甲巯咪唑治疗Graves病的疗效及其对促甲状腺激素受体抗体(TRAb)的影响分析[J].国际医药卫生导报,2014,20(4): 531-534.DOI:10.3760/ cma.j.issn.1007-1245.2014.04.032.
[9] Gao C,Li T,Liu J,et al.Endothelial functioning and hemodynamic parameters in rats with subclinical hypothyroid and the effects of thyroxine replacement[J].PLoS One,2015,10(7):e0131776.DOI:10.1371/journal.pone.0131776.
[10] 黄婧,郭天康,刘静,等.亚临床甲状腺功能减退大鼠骨代谢改变及左旋甲状腺素疗效[J].中华骨质疏松和骨矿盐疾病杂志,2015,8(1): 43-47.DOI:10.3969/j.issn.1674-2591.2015.01.008.
[11] 陈巍,高天舒,张凤暖,等.甲巯咪唑致亚临床甲减大鼠模型评价 [J].长春中医药大学学报,2017,33(1):43-46.DOI:10.13463/j.cczyy.2017.01.015.
[12] Tank JC,Weiner DS,Jacquet R,et al.The effects of hypothyroidism on the proximal femoral physis in miniature swine[J].J Orthop Res,2013,31(12):1986-1991. DOI:10.1002/jor.22467.
[13] Chen J,Ortmeier SB,Savinova OV,et al.Thyroid hormone induces sprouting angiogenesis in adult heart of hypothyroid mice through the PDGF-Akt pathway[J].J Cell Mol Med,2012,16(11):2726-2735.DOI:10.1111/j.1582-4934.2012.01593.x.
[14] Lu L,Yu X,Teng W,et al.Treatment with levothyroxine in pregnant rats with subclinical hypothyroidism improves cell migration in the developing brain of the progeny[J].J Endocrinol Invest,2012,35(5):490-496.DOI:10.3275/7967.
[15] 杨瑞霞,陈如泉.温肾方对亚临床甲状腺功能减退模型大鼠心肌组织 T3及甲状腺激素受体的影响[J].中医学报,2013, 28(7):989-991.DOI:10.16368/j.issn.1674-8999.2013.07.044.
[16] 于晓会,刘爱华,朱帅俊,等. 孕期亚临床甲减大鼠模型的建立 [J]. 实用预防医学, 2015,22(6): 686-689.DOI:10.3969/j.issn.1006-3110.2015.06.014.
[17] Ge JF,Peng L,Hu CM,et al.Impaired learning and memory performance in a subclinical hypothyroidism rat model induced by hemi-thyroid electrocauterisation[J].J Neuroendocrinol,2012,24(6):953-961.DOI:10.1111/j.1365-2826.2012.02297.x.
[18] Ge JF,Xu YY,Li N,et al.Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization[J].Endocr J,2015,62(10):927-938.DOI:10.1507/endocrj.EJ15-0253.
[19] Zhang X,Song Y,Feng M,et al.Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver[J].J Lipid Res,2015,56(5):963-971. DOI:10.1194/jlr.M047654.
[20] 王琦,于春晓,高聆,等.甲状腺激素调节肝脏 AMPKαThr 172而非 Ser 173的磷酸化[J]. 山东大学学报(医学版), 2014, 52(6): 22-27.DOI:10.6040/j.issn.1671-7554.0.2013.611.

相似文献/References:

[1]孙敏讷,段宇.老年亚临床甲状腺功能减退症的诊治特点[J].国际内分泌代谢杂志,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
 Sun Minne,Duan Yu..Diagnositc and therapeutic characteristics of subclinical hypothyroidism in elderly people[J].International Journal of Endocrinology and Metabolism,2014,(04):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
[2]张建萍,孟召伟,谭建,等.甲状腺静态显像诊断双异位甲状腺的6年回顾性研究[J].国际内分泌代谢杂志,2015,(03):166.[doi:10.3760/cma.j.issn.1673-4157.2015.03.006]
 Zhang Jianping*,Meng Zhaowei,Tan Jian,et al.Scintigraphic detection of dual ectopic thyroid: a six-year retrospective study[J].International Journal of Endocrinology and Metabolism,2015,(04):166.[doi:10.3760/cma.j.issn.1673-4157.2015.03.006]
[3]尹飞,李菲,李志红.亚临床甲状腺功能异常与骨质疏松[J].国际内分泌代谢杂志,2015,(04):258.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
 Yin Fei,Li Fei,Li Zhihong..Subclinical thyroid dysfunction and osteoporosis[J].International Journal of Endocrinology and Metabolism,2015,(04):258.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
[4]田瑗 刘龙 王莹 崔兰.亚临床甲状腺功能减退症与冠心病及其危险因素的相关性研究[J].国际内分泌代谢杂志,2015,(05):298.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.003]
 Tian Yuan*,Liu Long,Wang Ying,et al.Correlation of subclinical hypothyroidism with coronary heart disease and its risk factors[J].International Journal of Endocrinology and Metabolism,2015,(04):298.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.003]
[5]孟祥慧 徐书杭 陈国芳 刘超.二甲双胍在甲状腺癌防治中的作用[J].国际内分泌代谢杂志,2018,38(04):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
 Meng Xianghui*,Xu Shuhang,Chen Guofang,et al.Role of metformin in prevention and treatment of thyroid cancer[J].International Journal of Endocrinology and Metabolism,2018,38(04):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
[6]王珊珊 俞冰鸿 傅雯雯 杨艳辉 孔岩 王靖宇 常宝成 郑妙艳 杨菊红 王颖许杰 单春艳.亚临床甲状腺功能减退症与2型糖尿病肾功能损伤的相关性研究[J].国际内分泌代谢杂志,2019,39(06):368.[doi:10.3760/cma.j.issn.1673-4157.2019.06.002]
 Wang Shanshan,Yu Binghong,Fu Wenwen,et al.Correlation between subclinical hypothyroidism and renal function injury in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2019,39(04):368.[doi:10.3760/cma.j.issn.1673-4157.2019.06.002]
[7]何志伟,黄文彬,杨雪,等.下丘脑-垂体-甲状腺轴对胰岛β细胞的调控作用[J].国际内分泌代谢杂志,2023,43(06):517.[doi:10.3760/cma.j.cn121383-20220928-09053]
 He Zhiwei,Huang Wenbin,Yang Xue,et al.Regulation of the hypothalamic-pituitary-thyroid axis on islet β cells[J].International Journal of Endocrinology and Metabolism,2023,43(04):517.[doi:10.3760/cma.j.cn121383-20220928-09053]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81471009); 北京市卫生系统高层次卫生技术人才培养计划(2014-3-013)
通信作者:杨光燃,Email: gr.yang@ccmu.edu.cn
更新日期/Last Update: 2018-04-30